Home/Filings/4/0001645113-22-000024
4//SEC Filing

DOYLE WILLIAM F 4

Accession 0001645113-22-000024

CIK 0001645113other

Filed

Mar 8, 7:00 PM ET

Accepted

Mar 9, 4:48 PM ET

Size

5.0 KB

Accession

0001645113-22-000024

Insider Transaction Report

Form 4
Period: 2022-03-08
DOYLE WILLIAM F
Director10% Owner
Transactions
  • Sale

    Ordinary Shares

    2022-03-08$70.10/sh2,385$167,189552,013 total
Footnotes (1)
  • [F1]Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of the Restricted Stock Units. This sale is mandated by the issuer's award agreement under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the reporting person.

Issuer

NovoCure Ltd

CIK 0001645113

Entity typeother

Related Parties

1
  • filerCIK 0001194459

Filing Metadata

Form type
4
Filed
Mar 8, 7:00 PM ET
Accepted
Mar 9, 4:48 PM ET
Size
5.0 KB